55150-434 : DexrazoxaneDexrazoxane Kit
NDC: | 55150-434 |
Labeler: | Auromedics Pharma LLC |
Product Type: | Human Prescription Drug |
Drug Name: | Dexrazoxane |
Dosage Form: | Kit |
Application #: | ANDA200752 |
Rev. Date: |
NDC Package Codes:
- 55150-434-01: 1 KIT IN 1 PACKAGE (55150‑434‑01) * 25 ML IN 1 VIAL, SINGLE‑DOSE (55150‑432‑01) * 25 ML IN 1 VIAL (55150‑433‑01)
- 55150-434-02: 1 KIT IN 1 PACKAGE (55150‑434‑02) * 25 ML IN 1 VIAL, SINGLE‑DOSE (55150‑432‑02) * 25 ML IN 1 VIAL (55150‑433‑02)
Related Products:
Based on records with the same trade name.- 55150-437 DexrazoxaneDexrazoxane Kit by Auromedics Pharma LLC
- 0143-9247 Dexrazoxane 10 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by West-ward Pharmaceuticals Corp
- 0143-9248 Dexrazoxane 10 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by West-ward Pharmaceuticals Corp
- 42605-029 Dexrazoxane 10 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Thymoorgan Gmbh Pharmazir & Co. K.g
- 42605-030 Dexrazoxane 10 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Thymoorgan Gmbh Pharmazir & Co. K.g
- 47781-578 Dexrazoxane 500 mg/50ml Intravenous Injection, Powder, Lyophilized, for Solution by Alvogen Inc.
- 51991-942 Dexrazoxane 500 mg/50ml Intravenous Injection, Solution by Breckenridge Pharmaceutical, Inc.
- 68083-195 Dexrazoxane 500 mg/50ml Intravenous Injection, Powder, Lyophilized, for Solution by Gland Pharma Limited
- 68083-388 Dexrazoxane 250 mg/25ml Intravenous Injection, Powder, Lyophilized, for Solution by Gland Pharma Limited
- 72266-101 Dexrazoxane 500 mg/50ml Intravenous Injection, Powder, Lyophilized, for Solution by Fosun Pharma USA Inc.
- 72266-235 Dexrazoxane 250 mg/25ml Intravenous Injection, Powder, Lyophilized, for Solution by Fosun Pharma USA Inc.
- 72611-716 Dexrazoxane 500 mg/50ml Intravenous Injection, Powder, Lyophilized, for Solution by Almaject, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 55150-431Next: 55150-437 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.